Regenerative medicine in China: main progress in different fields

Biao Cheng; Shu-Liang Lu; Xiao-Bing Fu

Your Location：

Home >

Browse articles >

Regenerative medicine in China: main progress in different fields

REVIEW | Updated：2026-03-12

- Regenerative medicine in China: main progress in different fields
- Regenerative medicine in China: main progress in different fields
- MMR 2016年3卷第3期页码：140-152
- Affiliations：
  
  1.Medical College of PLA, General Hospital of PLA, College of Life Sciences, Beijing 100853, China
  2.The Key Laboratory of Trauma Treatment & Tissue Repair of Tropical Area of PLA, Guangzhou 510010, China
  3.Shanghai Burns Institute, Ruijing Hospital, Shanghai Jiaotong University, Shanghai 200025, China
- Author bio：
  
  *: fuxiaobing@vip.sina.com
- Funds：
  
  the National Nature Science Foundation of China(81171812;81272105;81121004;81230041;81171798);the National Basic Science and Development Programme (973 Programme)(2012CB518105);the National Science and Technology Major Project(2011ZXJ07104B-03B);the Health and Medical Treatment Collaborative Innovation Major Special Projects of Guangzhou(201508020253);the Science and Technology Key Project of Guangdong Province(2014B020212010)
- DOI：
  中图分类号：
- 纸质出版：2016-09
- Accepted：
Scan QR Code
Regenerative medicine in China: main progress in different fields[J]. MMR, 2016,3(3):140-152.

Biao Cheng, Shu-Liang Lu, Xiao-Bing Fu. Regenerative medicine in China: main progress in different fields[J]. Military Medical Research, 2016, 3(3): 140-152.
Regenerative medicine in China: main progress in different fields[J]. MMR, 2016,3(3):140-152. DOI：

Biao Cheng, Shu-Liang Lu, Xiao-Bing Fu. Regenerative medicine in China: main progress in different fields[J]. Military Medical Research, 2016, 3(3): 140-152. DOI：

摘要

Abstract

Regenerative medicine (RM) is an emerging interdisciplinary field of research and China has developed the research quickly and impressed the world with numerous research findings in stem cells

tissue engineering

active molecules and gene therapy. Important directions are induced differentiation of induced pluripotent stem and embryo stem cells as well as somatic stem cell differentiation potential and their application in trauma

burns

diseases of aging and nerve regeneration. The products ActivSkin and bone repair scaffolds have been approved and are applied in the clinic

and similar products are being studied. About 10 engineered growth-factor drugs for repair and regeneration have been approved and are used in the clinic. Gene therapy

therapeutic cloning and xenotransplantation are some of the strategies being studied. However

China needs to develop standards

regulations and management practices suitable for the healthy development of RM. Aspects that should be strengthened include sound administrative systems

laws

and technical specifications and guidelines; conservation of stem cell resources; emphasis on training and retention of talented stem cell researchers; and reasonable allocation of resources

diversification of investment and breakthroughs in key areas. Finally

broad and deep international cooperation is necessary.

关键词

Keywords

references

Dennis C . Stem cells rise in the East . Nature . 2002 ; 419 : 334 - 6 .

Dennis C . Chinese fusion method promises fresh route to human stem cells . Nature . 2003 ; 424 : 711 .

Jin X , Zheng L , Zheng RH , Li YM . China’s policies on stem cell research: an opportunity for international collaborations . Nat Rev Mol Cell Biol . 2009 ; 10 : 286 .

Yuan W , Sipp D , Wang ZZ , Deng H , Pei D , Zhou Q , et al . Stem cell science on the rise in China . Cell Stem Cell . 2012 ; 10 : 12 - 5 .

Zhou Q , Ren X , Yang X , Yao Y , Yang W , Xia Y . Confronting Coming Medical Renovation—Progresson Stem Cell and Regenerative Medicine Research . Bull Chin Acad Sci . 2015 ; 30 ( 2 ): 262 - 271 .

Salter B , Cooper M , Dickins A . China and the global stem cell bioeconomy: an emerging political strategy? Regen Med . 2006 ; 1 : 671 - 83 .

McMahon DS , Thorsteinsdttir H , Singer PA , Daar AS . Cultivating regenerative medicine innovation in China . Regen Med . 2010 ; 5 : 35 - 44 .

Hvistendahl M . China’s Push in Tissue Engineering . Science . 2012 ; 338 : 900 - 2 .

Zhou Q , Ren X , Yang X , Yao Y , Yang W , Xia Y . Confronting Coming Medical Renovation —Progresson Stem Cell and Regenerative Medicine Research . Bulletin of the Chinese Academy of Sciences , 2015 ; 30 : 262 - 71 .

Liao L , Li L , Zhao RC . Stem cell research in China . Philos Trans R Soc Lond B Biol Sci . 2007 ; 362 : 1107 - 12 .

Salter B , Qiu RZ . Bioethical governance and basic stem cell science: China and the global biomedicine economy . Sci Public Policy . 2009 ; 36 : 47 - 59 .

Liu H , Zhu F , Yong J , Zhang P , Hou P , Li H , et al . Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts . Cell Stem Cell . 2008 ; 3 : 587 - 90 .

Zou K , Yuan Z , Yang Z , Luo H , Sun K , Zhou L , et al . Production of offspring from a germline stem cell line derived from neonatal ovaries . Nat Cell Biol . 2009 ; 11 : 631 - 6 .

Li W , Shuai L , Wan H , Dong M , Wang M , Sang L , et al . Androgenetic haploid embryonic stem cells produce live transgenic mice . Nature . 2012 ; 490 : 407 - 11 .

Esteban MA , Wang T , Qin B , Yang J , Qin D , Cai J , et al . Vitamin C enhances the generation of mouse and human induced pluripotent stem cells . Cell Stem Cell . 2010 ; 6 : 71 - 9 .

Fang HT , Zhang B , Pan XF , Gao L , Zhen T , Zhao HX , et al . Bortezomib interferes with C-KIT processing and transforms the t(8;21)-generated fusion proteins into tumor-suppressing fragments in leukemia cells . Proc Natl Acad Sci U S A . 2012 ; 109 : 2521 - 6 .

Vogel G . Embryonic stem cells not so stealthy after all . Science . 2002 ; 297 : 175 - 7 .

Hou P , Li Y , Zhang X , Liu C , Guan J , Li H , et al . Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds . Science . 2013 ; 341 : 651 - 4 .

Yang H , Shi L , Wang BA , Liang D , Zhong C , Liu W , et al . Generation of genetically modified mice by oocyte injection of androgenetic haploid embryonic stem cells . Cell . 2012 ; 149 : 605 - 17 .

Zhu J , Zhou L , XingWu F . Tracking neural stem cells in patients with brain trauma . N Engl J Med . 2006 ; 355 : 2376 - 8 .

Sheng ZY , Fu XB , Cai S , Lei YH , Sun TZ , Bai XD , et al . Regeneration of functional sweat gland-like structures by transplanted differentiated bone marrow mesenchymal stem cells . Wound Rep Reg . 2009 ; 17 : 427 - 35 .

Wang S , Cheng H , Dai G , Wang X , Hua R , Liu X , et al . Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury . Brain Res . 2013 ; 1532 : 76 - 84 .

Cyranoski D . Stem-cell therapy faces more scrutiny in China . Nature . 2009 ; 459 : 146 - 7 .

[No authors listed] . Stem-cell laws in China fall short . Nature . 2010 ; 467 : 633 .

Fu X , Shen Z , Chen Y , Xie J , Guo Z , Zhang M , et al . Randomised placebo controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns . Lancet . 1998 ; 352 : 1661 - 4 .

Fu X , Sun X , Li X , Sheng Z . Dedifferentiation of epidermal cells to stem cells in vivo . Lancet . 2001 ; 358 : 1067 - 8 .

Zhang C , Fu X , Chen P , Bao X , Li F , Sun X , et al . Dedifferentiation derived cells exhibit phenotypic and functional characteristics of epidermal stem cells . J Cell Mol Med . 2010 ; 14 : 1135 - 45 .

Stocum DL . Development. A tail of transdifferentiation . Science . 2002 ; 298 : 1901 - 3 .

Jiang TJ , Sun JH . The supervision status of stem cell and revelation to China . Chin J Soc Med . 2016 ; 33 : 117 - 20 .

Fu X . Regenerative medicine research in China: demands and clinical translation . Med J Chin PLA . 2012 ; 37 ( 3 ): 169 - 71 .

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Bioengineered skin organoids: from development to applications

Repair cell first, then regenerate the tissues and organs

Application of stem cells in tissue engineering for defense medicine

The national and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050

National age-specific mortality trends for cervical and breast cancers in urban-rural areas of China from 2009 to 2021: a population-based analysis